3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
32
Breast
31
Thoracic
11
Other
11
Lymphoid
9
Genitourinary
7
Other hematologic neoplasm
6
Gynecologic
5
Endocrine
4
Dermatologic
4
Classical hematology
3
CNS
3
Sarcoma
2
Plasma cell
2
Myeloid
2
Head & Neck
1
Conditions
Myelodysplastic Syndromes
999
Leukemia, Myeloid, Acute
826
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
532
Leukemia
519
Precursor Cell Lymphoblastic Leukemia-Lymphoma
501
Myeloproliferative Disorders
438
Lymphoma, Non-Hodgkin
339
Multiple Myeloma
327
Hodgkin Disease
313
Leukemia, Lymphocytic, Chronic, B-Cell
304
Leukemia, Myelomonocytic, Chronic
299
Primary Myelofibrosis
285
Lymphoma
267
Leukemia, Myeloid, Chronic-Phase
254
Leukemia, Myeloid, Accelerated Phase
208
Blast Crisis
208
Lymphoma, Mantle-Cell
206
Lymphoma, Follicular
204
Burkitt Lymphoma
200
Lymphoma, Large B-Cell, Diffuse
192
Lymphoma, B-Cell, Marginal Zone
184
Congenital Abnormalities
166
Lymphoma, Large-Cell, Immunoblastic
165
Polycythemia Vera
162
Myelodysplastic-Myeloproliferative Diseases
159
Neoplasms, Plasma Cell
152
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
145
Anemia, Refractory, with Excess of Blasts
127
Thrombocythemia, Essential
125
Lymphoma, T-Cell, Cutaneous
124
Interventions
Diet, Mediterranean
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Inflammation
×
Myeloid
×
Clear all
NCT05969821
2026-03-23
CHIS
Assistance Publique - Hôpitaux de Paris
Not yet recruiting
5,000 enrolled
NCT03907436
2020-03-24
NUTRIENT
University of California, Irvine
Phase NA
Completed
30 enrolled